HomeNewsPackaging

Activated Rispharm, will be introduced at Pharmapack 2022

Activated Rispharm, will be introduced at Pharmapack 2022

Activated Rispharm, the first-to-market multidose antimicrobial dropper to help prevent eye microbial infections for patients, will be introduced at Pharmapack 2022 (18th & 19th May in Paris). Developed in a strategic commercial partnership between Berry Global, a leading provider of innovative packaging and engineered products, and Pylote, a key player in the industrial mineral chemistry, the solution will be presented on the Berry Global stand (A60). Activated Rispharm  will also be submitted into the 2022 Pharmapack Awards and will be seen at the exhibition’s Innovation Gallery.

Activated Rispharm is a new multidose eye dropper with nozzle and cap activated to kill bacteria and viruses continuously to deliver hygienic doses at each use and, thus, to reduce infection risks. The product delivers unique antimicrobial protection properties resulting from the combination of Pylote’s expertise in mineral chemistry that helps protect patients/users from the risk of microbial infections, with Berry Global ’s expertise in sustainable healthcare packaging. Pylote’s patented mineral technology – microspheres – is embedded into the resin masterbatch, and is fully recyclable, thus supporting efforts towards sustainability. 

Among the advantages mentioned by the company are:

  • Proven and certified antimicrobial mineral protection of dropper tip where over 85% of the contamination of the drops is found according to clinical study (Nentwich et al, Br J Ophthalmol 91(10): 1265-68).
  • Proven and certified effectiveness against Adenovirus type 3 (conjunctivitis), Escherichia Coli and Staphylococcus aureus.
  • Allows patients to have hygienic applications for every use with a multidose dropper.
  • Reduces the amount of plastic waste by 16 times for one month treatment compared to monodose solutions.
  • No change in patient treatment methods.
  • Fully compliant, stable and biocompatible while certified non-irritant and non-cytotoxic technology (ISO10993:2010)
  • No modifications required to packaging design or existing manufacturing/filling processes.
Read more on:
More news about: packaging | Published by Content editor | May - 17 - 2022 | 896

Last news about this category


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members